Histopathological features and current scoring systems for semiquantitative assessment of nonalcoholic fatty liver disease

Experimental and Clinical Hepatology

Volumn 4, Issue 1, 2008, Pages 48-54

  Gabriel, Andrzej ^a   Kukla, Michał ^a   Ziółkowski, Adam ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Fibrosis; Histopathological criteria; Inflammation; Steatohepatitis; Steatosis

Indexed keywords

CONSENSUS DEVELOPMENT; HEPATITIS; HISTOPATHOLOGY; HUMAN; LIVER BIOPSY; LIVER FIBROSIS; MEDICAL SOCIETY; NONALCOHOLIC FATTY LIVER; QUANTITATIVE DIAGNOSIS; REVIEW; SCORING SYSTEM;

EID: 76749115548     PISSN: 17343038     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (33)

1. Brunt EM: Pathology of fatty liver disease: Modern Pathology 2007; 20:40-48.
2. Reid AE: Nonalcoholic steatohepatitis. Gastroenterology 2001; 121: 710-23.
3. Youssef WI, Mc Culloough AJ: Steatohepatitis in obese individuals. Best practice and research. Clin Gastroentrol 2002; 16: 73347.
4. Marchesini G, Babini M: Nonalcoholic fatty liver disease and the metabolic syndrome. Minerva Cardioangiol 2006; 54: 229-39.
5. Marceau P, Biron S, Hould FS et al: Liver pathology and the metabolic syndrome X in severe obesity. J Clin Endocrinol Metab 1999; 84: 1513-17.
6. Festi D, Colecchia A, Sacco T, Bondi E, Roda E, Marchesini G: Hepatic steatosis in obese patients: clinical aspects and prognostic significance. Obesity Reviwes 2004; 5: 2742.
7. Fong DR. Nehra V, Lindor KD, Bunchman AL: Metabolic and nutritional considerations in non-alcoholic fatty liver. Hepatology 2000; 32: 3-10.
8. Ramesh S, Sanyal AJ: Evaluation and management of non-alcoholic steatohepatitts. J Hepatol 2005; 42 suppl: 2-12.
9. Diehl Am, Li ZP, Lin HZ, Yang SQ: Cytokines and the pathogenesis of non-alcoholic steatohepatitis. Gut 2005; 54: 303-6.
10. Adams LA, Angulo P: Recent concepts in non-alcoholic fatty liver disease. Diabet Med 2005; 22: 1129-33.
11. Day C, James O: Steatohepatitis: a tale of two "hits". Gastroenterology 1 998; 114: 842-5.
12. Angulo P: Nonalcoholic fatty liver disease. N Engl J Med 2002; 346: 1221-31.
13. Clark JM, Brancati FL, Diehl AM: Nonalcoholic fatty liver disease. Gastroentetology 2002; 122: 1649-57.
14. Marrero JA, Fontana RJ, Su GI et al: NAFLD may be a common underlying liver disease in patients with hepatocellular carcinoma in the United States. Hepatology 2002; 36: 1439-54.
15. Neuschwander-Terti BA, CaIdwell SH: Nonalcoholic Steatohepatitis: Summary of an AASLD Single Topic Conference. Hepatology 2003; 37: 1202-19.
16. Albano E, Mottaran E, Redick JA et al: Immune response toward lipid peroxidation products at a predictor of progression of non-alcoholic fatty liver disease to advanced fibrosis. Gut 2005; 54: 987-93.
17. Ludwig J, Viggiano TR, McGill DB, Ott BJ: Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clinic Proc 1980; 55: 434-8.
18. Matteoni CA, Youossi ZM, Gramlich T et al: Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 1999; 116: 1413-19.
19. Dixon JB, Bhathal PS, O'Brien PE: Nonalcoholic fany liver disease: Predictors of tionalcoholic stearohepatitis and liver fibrosis in the severely obese. Gastroenterology 2001; 121:91-100.
20. Roberts EA: Steatohepatitis in children. Best Pract Rev Clin Gastroenterol 2002; 16:749-65.
21. Roberts EA: Non-alcoholic fatty liver disease (NAFLD) in children. Front Biosci 2005; 10: 2306-18.
22. Schwimmer JB, Behling C, Newbury R et al: Histopathology of pediatric nonalcoholic fatty liver disease. Hepatology 2005; 9: 641-49.
23. Hübscher SG: Histological assessment of non-alcoholic fatty liver disease. Histopathology 2006; 49: 450-65.
24. Brunt EM,Janney C.G, Di Bisceglie AM, Neuschwander-Teri BA, Bacon BR: Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 1999; 94: 2467-74.
25. Kleiner DL, Brunt EM, Van Natta M et al: Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005;41: 1313-21.
26. Mendler MH, Kanel G, Govindrajan S: Proposal for histopathological scoring and grading system for nonalcoholic fatty liver disease. Liver Int 2005; 25: 294-304.
27. Dixon JB, Bhathal PS, Hughes NR et al: Improvenient in liver histological analysis with weight loss. Hepatology 2004; 39: 1647-54.
28. Ishak K, Baptists A, Bianchi L et al: Histological grading and staging of chronic hepatitis. J Hepatol 1995; 22: 696-9.
29. Lee RG: Nonalcoholic steatohepatitis tightening the morphological screws on a hepatic rambler. Hepatology 1995; 21: 1742-43.
30. Ziółkowski A, Wyleżoł M, Kukla M et al: Factors associated with steatosis and necroinflammatory activity in morbidly obese patients with non-alcoholic fatty liver disease. Pol J Environ Stud 2005; 14 suppl. 2: 417-20.
31. Kukla M, Żwitska-Korczala K, Gabriel A et al: Liver tissue alterations in morbidly obese patients undergoing bariatric surgery. Exp Clin Hepatol 2007; 3(3): 12-18.
32. Ziółkowski A, Wyleżoł H, Kukla H et al: The comparison of scoring scales for liver biopsy assessment in morbidly obese patients undergoing bariatric surgery. Obes Surg 2005; 15(9): 1309-14.
33. Dixon JB: Non-alcoholic fatty liver disease: scoring systems need standardization, but are we ready? Obes Surg 2005; 9: 1314-15.